These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14679747)

  • 1. [Effect of clarithromycin on pathogenic factors in Helicobacter pylori].
    Nohata K; Ota M; Hasegawa T; Tsuzuki T; Ando T; Ina K; Kusukami K
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():51-3. PubMed ID: 14679747
    [No Abstract]   [Full Text] [Related]  

  • 2. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
    Nobata K; Ina K; Ohta M; Kawamura-Sato K; Tsuzuki T; Ando T; Kusugami K
    Dig Liver Dis; 2002 Jul; 34(7):489-97. PubMed ID: 12236482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
    Hershko C; Hoffbrand AV; Keret D; Souroujon M; Maschler I; Monselise Y; Lahad A
    Haematologica; 2005 May; 90(5):585-95. PubMed ID: 15921373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial ecology and treatment of Helicobacter pylori infections: review.
    Adamsson I; Edlund C; Nord CE
    J Chemother; 2000 Feb; 12(1):5-16. PubMed ID: 10768510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell envelope characteristics of Helicobacter pylori: their role in adherence to mucosal surfaces and virulence.
    Clyne M; Drumm B
    FEMS Immunol Med Microbiol; 1996 Dec; 16(2):141-55. PubMed ID: 8988394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
    Furuta T; Soya Y; Sugimoto M; Shirai N; Nakamura A; Kodaira C; Nishino M; Okuda M; Okimoto T; Murakami K; Fujioka T; Hishida A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1810-5. PubMed ID: 17914955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
    Ozdemir A; Mas MR; Sahin S; Sağlamkaya U; Ateşkan U
    Quintessence Int; 2001 Feb; 32(2):131-4. PubMed ID: 12066673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors of Helicobacter pylori affecting its gastric colonization in Mongolian gerbils.
    Iwao E; Hirayama F; Takagi S; Yokoyama Y; Ikeda Y
    J Gastroenterol; 1999; 34 Suppl 11():47-54. PubMed ID: 10616766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
    Miyamoto M; Haruma K; Yoshihara M; Sumioka M; Kamada T; Ito M; Masuda H; Nishisaka T; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):371-5. PubMed ID: 12743778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastritis and Helicobacter pylori: forty years of antibiotic therapy.
    Lieber CS
    Digestion; 1997; 58(3):203-10. PubMed ID: 9243114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
    Cadranel S; Bontemps P; Van Biervliet S; Alliet P; Lauvau D; Vandenhoven G; Vandenplas Y
    Acta Paediatr; 2007 Jan; 96(1):82-6. PubMed ID: 17187610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiological mechanism of Helicobacter pylori infections].
    Takagi A; Miwa T
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):808-12. PubMed ID: 9648429
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis.
    Kadayifçi A; Gullu IH; Aka H
    Ann Pharmacother; 1997 Jun; 31(6):788. PubMed ID: 9184727
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial factors and immune pathogenesis in Helicobacter pylori infection.
    Shimoyama T; Crabtree JE
    Gut; 1998 Jul; 43 Suppl 1(Suppl 1):S2-5. PubMed ID: 9764030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits.
    De Francesco V; Zullo A; Ierardi E; Giorgio F; Perna F; Hassan C; Morini S; Panella C; Vaira D
    J Antimicrob Chemother; 2010 Feb; 65(2):327-32. PubMed ID: 20008044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.